230 related articles for article (PubMed ID: 32486903)
1. Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters.
Kim V; Wal TV; Nishi MY; Montenegro LR; Carrilho FJ; Hoshida Y; Ono SK
Pharmacogenomics; 2020 Jun; 21(9):575-586. PubMed ID: 32486903
[No Abstract] [Full Text] [Related]
2. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
Chowbay B; Zhou S; Lee EJ
Drug Metab Rev; 2005; 37(2):327-78. PubMed ID: 15931768
[TBL] [Abstract][Full Text] [Related]
3. Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Li J; Zhang L; Zhou H; Stoneking M; Tang K
Hum Mol Genet; 2011 Feb; 20(3):528-40. PubMed ID: 21081654
[TBL] [Abstract][Full Text] [Related]
4. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
5. Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.
Yi S; An H; Lee H; Lee S; Ieiri I; Lee Y; Cho JY; Hirota T; Fukae M; Yoshida K; Nagatsuka S; Kimura M; Irie S; Sugiyama Y; Shin DW; Lim KS; Chung JY; Yu KS; Jang IJ
Pharmacogenet Genomics; 2014 Oct; 24(10):477-85. PubMed ID: 25029633
[TBL] [Abstract][Full Text] [Related]
6. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.
Jittikoon J; Mahasirimongkol S; Charoenyingwattana A; Chaikledkaew U; Tragulpiankit P; Mangmool S; Inunchot W; Somboonyosdes C; Wichukchinda N; Sawanpanyalert P; He Y; McLeod HL; Chantratita W
J Hum Genet; 2016 Feb; 61(2):119-27. PubMed ID: 26423926
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation and pharmacogenomics.
Georgitsi M; Zukic B; Pavlovic S; Patrinos GP
Pharmacogenomics; 2011 May; 12(5):655-73. PubMed ID: 21619428
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
Hirota T; Takane H; Higuchi S; Ieiri I
Curr Drug Metab; 2008 Jan; 9(1):34-8. PubMed ID: 18220569
[TBL] [Abstract][Full Text] [Related]
9. Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.
Bonifaz-Peña V; Contreras AV; Struchiner CJ; Roela RA; Furuya-Mazzotti TK; Chammas R; Rangel-Escareño C; Uribe-Figueroa L; Gómez-Vázquez MJ; McLeod HL; Hidalgo-Miranda A; Parra EJ; Fernández-López JC; Suarez-Kurtz G
PLoS One; 2014; 9(11):e112640. PubMed ID: 25419701
[TBL] [Abstract][Full Text] [Related]
10. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Lubomirov R; di Iulio J; Fayet A; Colombo S; Martinez R; Marzolini C; Furrer H; Vernazza P; Calmy A; Cavassini M; Ledergerber B; Rentsch K; Descombes P; Buclin T; Decosterd LA; Csajka C; Telenti A;
Pharmacogenet Genomics; 2010 Apr; 20(4):217-30. PubMed ID: 20139798
[TBL] [Abstract][Full Text] [Related]
11. Development of a broad-based ADME panel for use in pharmacogenomic studies.
Brown AM; Renaud Y; Ross C; Hansen M; Mongrain I; Valois D; Carleton BC; Hayden MR; Dubé MP; Tardif JC; Phillips MS
Pharmacogenomics; 2014 Jun; 15(9):1185-95. PubMed ID: 25141894
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of membrane transporters: past, present and future.
Yee SW; Chen L; Giacomini KM
Pharmacogenomics; 2010 Apr; 11(4):475-9. PubMed ID: 20350125
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.
Sakaeda T; Nakamura T; Okumura K
Curr Top Med Chem; 2004; 4(13):1385-98. PubMed ID: 15379652
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
15. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
16. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
Cerda A; Hirata MH; Hirata RD
Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
[TBL] [Abstract][Full Text] [Related]
18. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Serpe L; Canaparo R; Scordo MG; Spina E
Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
